News
CDC panel backs broader RSV vaccine use
The CDC’s Advisory Committee on Immunization Practices voted April 16 to expand use of respiratory syncytial virus vaccines among high-risk adults. The updated recommendation calls for a single vaccine dose for adults ages 50-59 with underlying medical conditions who are at increased risk for severe RSV illness.
7d
Officials at the Department of Health and Human Services have struggled to find records belonging to Dr. Tom Shimabukuro, the director of the CDC’s Immunization Safety Office.
A formal vote on the new guidance is expected in June by the CDC's Advisory Committee on Immunization Practices. The panel's votes are important because they influence ways that the federal ...
An independent vaccine advisory committee to the Centers for Disease Control and Prevention met to discuss and vote on ...
More: CDC panel lowers age for key vaccine. What older adults should know. The meeting was abruptly delayed in February just days after Robert F. Kennedy Jr., a long-time vaccine skeptic ...
NBC News, citing two sources familiar with the plan, reports that the CDC is expected to hand over multiple sets of vaccine safety data to a “senior data analyst” at HHS named David Geier.
It was reported this month that the CDC would launch a new investigation looking at possible links between vaccines and autism. Instead, the Department of Health and Human Services, led by ...
The U.S. Centers for Disease Control and Prevention (CDC) reportedly has plans to perform a large study on a “possible connection” between vaccines and autism—a topic of interest to Robert F.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback